AI-Guided Milestone | Watson Options | The Unmatched
“Fear of AI is a decadent, first-world problem.” UPenn Prof. Saurabh Jha during his keynote speech at the recently-posted Michigan AI 2020 Symposium. Imaging Wire Sponsors…
Invisible Rads | PACS Miles | AI Education
“We may find ourselves emerging from our bunkers in the future, troglodytes blinking as we encounter daylight, strangers to those with whom we once spoke…” Mercy…
MRI PCa Screening | FDA AI Bias | Angio+MRI
“Whether it’s AI or traditional models, we have always been complacent . . .” MGH’s Connie Lehman, MD, PhD on breast imaging’s biased history. Imaging Wire…
Making an OEM
“We will become the largest global player in secondary screening and diagnostics for women with dense breasts. . .” SmartBreast CEO, Dr. James Hugg, on his…
AI Optimism | Pentagon POCUS | Midea Enters
“AI will become our foe unless the human touch to radiology is restored,” Frank Lexa, MD, MBA and Saurabh Jha, MD, urging radiologists to “go beyond…
Prostate MRgFUS | DeepCAC CV Risk | Visage AI
“If the medical team cannot clinically tell that this is a massive groin hernia then please consider retraining as medical professionals.” One radiologist’s EHR note after…
COVID Severity AI | Risk Milestone | ED Disparities
“Something else is going on here that’s beyond the clinical, that’s beyond the diagnoses,” UPMC Children’s Hospital’s Jennifer Marin MD, after her study revealed major emergency…
Very Different AI Pathways | Another Extender Debate
“This isn’t about patient safety, this is just protectionism.” One radiographer’s response to the Royal Australian and New Zealand College of Radiologists’ position against radiographers “seeking…
Patient-Aided Dx | M&A Probe | Myeloma MRI
“This clearly needs to change.” King’s College London professor of cancer imaging, Vicky Goh, on the UK’s widespread use of X-ray to diagnose myeloma, even though…
FDA Siege | Debiased AI | Inpatient Screening
“We cannot allow unregulated AI to make clinical decisions.” Hardian Health’s Dr. Hugh Harvey in response to the FDA’s move to waive regulatory approval requirements for…
